Podocyte Pathogenic Bone Morphogenetic Protein‐2 Pathway and Immune Cell Behaviors in Primary Membranous Nephropathy

Documenti analoghi

• Activin‐A Regulates Bone Morphogenetic Protein Signaling in Pulmonary Endothelial Cells Without Affecting Bone Morphogenetic Protein Type‐II Receptor Expression
  di: Benjamin J. Dunmore, et al.
  Pubblicazione: (2025)
• Xylt2 Knockout Eliminates O‐Xylosylation and Enhances Bone Morphogenetic Protein 2 Production in Chinese Hamster Ovary Cells
  di: Lin Han, et al.
  Pubblicazione: (2026)
• GMSCs ‐Derived Exosome ZHX2 Improves Diabetes Nephropathy by Blocking AGEs / RAGE / NLRP3 Pathway to Inhibit Podocyte Pyroptosis and Inflammatory Response
  di: Shaobo Wang, et al.
  Pubblicazione: (2026)
• TangNaikang Formula Alleviates Podocyte Injury in Diabetic Nephropathy by Modulating the SHIP2/PI3K/AKT Pathway
  di: Tao Yang, et al.
  Pubblicazione: (2025)
• Correlations of the Complement Proteins MASP‐2 and MASP‐3 With Clinical Severity and Short‐Term Outcomes in Primary Membranous Nephropathy Patients
  di: Tong Liu, et al.
  Pubblicazione: (2025)